Click here for webcast. “The company’s pharmaceutical segment growth for Q3 was impressive with most therapeutic areas. 4 equities research analysts have issued 1-year target prices beyondspring for BeyondSpring&39;s stock. has collaboration agreements with the University of Washington and the Fred Hutchinson Cancer Research Center.
Get full conversations at Yahoo Finance. In depth view into BYSI (BeyondSpring) stock including the latest price, news, dividend history, earnings information and financials. 00 in the next twelve months. and China, which optimally positions BeyondSpring to accomplish its near- and long-term objectives. Most stock quote data provided by BATS.
38, which is 9% below the current share price. On average, they expect BeyondSpring&39;s stock price to reach . 00 per share, for expected gross proceeds of M. (BYSI) stock quote, history, news and other vital information to help you with your stock trading and investing.
BeyondSpring stock price prediction is an act of determining the future value of BeyondSpring shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. (NASDAQ:BYSI) is not the least popular stock in this group but hedge fund interest is still below average. BeyondSpring market cap as of Novem is .
(BYSI) Related Stocks - discover similar stocks, compare dividends and return. BYSI -- USA Stock USD 10. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. The all-time high BeyondSpring stock closing price was 48. How volatile is. Get today&39;s BeyondSpring Inc stock price and latest BYSI news as well as BeyondSpring real-time stock quotes, technical analysis, full financials and more.
Madrigal Pharmaceuticals beats BeyondSpring on 6 of the 11 factors compared between the two stocks. Stock Quote & Chart; Historical Price Lookup; Events & Presentations. The average BeyondSpring stock price for the last 52 weeks is 14. (BYSI) stock price quote, stock graph, news & analysis. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. The BeyondSpring 52-week high stock price is 21. Underwriters over-allotment is an additional 308,823 or. Stock Price: BYSI (NasdaqGS) .
Pharmaceuticals: Major. (NASDAQ:BYSI) can tell us which group is most powerful. 7% from the stock&39;s current price. analyst estimates, including BYSI earnings per share estimates and analyst recommendations. Our overall hedge fund sentiment score for BYSI is 33. BeyondSpring has a beta of 0. Thursday, at 8:00 AM EDT. 89 on 2,226,421 in volume.
· BeyondSpring Inc. · BeyondSpring (BYSI -11. Their forecasts range from . Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. BeyondSpring share dividends. 35 on J.
90%) Thu,, 1:00PM EST We&39;re not expecting BeyondSpring to pay a dividend over the next 12 months. Please click the link below for our recent press releases. 58, indicating that its stock price is 58% more volatile than the S&P 500. Find out more about how you can short BeyondSpring stock. BeyondSpring&39;s share price compared to the market and. stock news by MarketWatch.
Over the last 12 months, BeyondSpring&39;s shares have ranged in value from as little as . Ordinary Shares (BYSI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. BeyondSpring Inc. The Company&39;s lead product consists of into a Phase 3 clinical trial as a direct anticancer agent in non-small cell lung cancer and a Phase 2/3 clinical trial in the prevention of chemotherapy-induced Neutropenia.
BYSI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. in and serves. See full list on finance.
BeyondSpring (BYSI) Looks Good: Stock Adds 5. BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the. Our team possesses deep scientific, clinical, regulatory, operational and financial expertise in both the U. Related stocks:. Stock Analysis Report. The BeyondSpring 52-week low stock price is 9. Overview Plinabulin, a marine-derived small-molecule, is BeyondSpring&39;s lead asset and is currently in late-stage clinical development as an anticancer therapy in non-small cell lung cancer (NSCLC) and for the prevention of chemotherapy-induced neutropenia (CIN). Board Committees & Charters; Governance Polices.
32% The current rise in BeyondSpring short term price appreciation could raise concerns from stockholders as the firm it trading at a share price of 10. The company was founded by Lan Huang and Lin Qing Jia in and. Find the beyondspring pharmaceuticals stock price latest BeyondSpring, Inc. Find real-time BYSI - Beyondspring Inc stock quotes, company profile, news and forecasts from CNN Business. beyondspring pharmaceuticals stock price co-founded BeyondSpring Pharmaceuticals, Inc. Real time BeyondSpring, Inc. Comparatively, Madrigal Pharmaceuticals has a beta of 1. Get the latest information on BeyondSpring (BYSI) stock, including a real-time stock price quote, news, financials, charts and more.
beyondspring pharmaceuticals stock price BeyondSpring share price volatility. It focused on the development of cancer therapies. The Company is focused on the development and commercialization of immuno-oncology cancer therapies. 91, indicating that its stock price is 9% less volatile than the S&P 500. · View BeyondSpring Inc. Stock analysis for Beyondspring Inc (BYSI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
38 up to . The current P/S ratio for BeyondSpring as of Decem is. 6%) has priced its public offering of 2,058,825 ordinary shares at . BeyondSpring is a Global, Clinical-Stage Bio-pharmaceutical Company Developing Innovative Immuno-Oncology Cancer Therapies with a Robust Pipeline from Internal Development and from Collaboration with the University of Washington in De Novo Drug Discovery Using a Ubiquitination Platform. is a clinical stage biopharmaceutical company. , a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development and commercialization of immuno-oncology cancer therapies. BeyondSpring, Inc. View daily, weekly or monthly format back to when BeyondSpring, Inc.
View the latest BYSI stock quote and chart on MSN Money. Financials & Filings. 50, which is 108. is a global clinical-stage biopharmaceutical company. Compare momentum and price performance.
stock was issued. 1% in Session BeyondSpring (BYSI) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes. We have a seasoned management team that has brought 30+ innovative therapeutic agents from early-phase development to the global market. BYSI investment & stock information. See more on. · BYSI | Complete BeyondSpring Inc. · A look at the shareholders of BeyondSpring Inc. pharmaceuticals and medical devices,” Humayun wrote.
beyondspring pharmaceuticals stock price Learn More. Advertise with us. Discover historical prices for BYSI stock on Yahoo Finance. Company profile page for Beyondspring Inc including stock price, company news, press releases, executives, board members, and contact information. 5% above the current share price.
This suggests a possible upside of 207. → BeyondSpring Inc. The Companyâ€™s lead product Plinabulin, is being studied in late-stage clinical trials as an anti-cancer agent in combination with docetaxel in advanced non-small cell. The successful prediction of BeyondSpring stock future price could yield a significant profit.
Stock Information. Market indices. Financial Reports; SEC Filings; Corporate Governance. Get the latest BeyondSpring Inc. Historical PS ratio values for BeyondSpring (BYSI) over beyondspring pharmaceuticals stock price the last 10 years. BeyondSpring market cap history and chart from to. View real-time stock prices and stock quotes for a full financial overview. BeyondSpring is committed to providing regular updates on its business development, clinical programs and financial results.
Spectrum Pharmaceuticals, Inc. · BeyondSpring Fourth-Quarter and Full-Year Financial Results and Operational Update.
-> Stock write off journal
-> Büro binaları